START TYPING AND PRESS ENTER TO SEARCH

ПЛАСТИЧЕСКИЕ МАТЕРИАЛЫ В СОВРЕМЕННОЙ ДЕТСКОЙ КАРДИОХИРУРГИИ

Drozdovsky_monography2016

Авторы:
Дроздовский Константин Викентьевич, кандидат медицинских наук (Минск, Беларусь)
e-mail: info@dhc.by

Линник Юрий Иванович (Минск, Беларусь)
e-mail:

Аннотация:
Монография посвящена изучению вопросов использования различных пластических материалов в современной детской кардиохирургии, необходимых для осуществления коррекции ряда врожденных пороков сердца. Монография представляет интерес не только для врачей-кардиохирургов, но и для детских хирургов, а также для врачей-ангиохирургов. На страницах издания можно найти новейшие сведения о преимуществах и недостатках используемых в настоящее время в кардиохирургии многочисленных пластических материалов. Предназначена для врачей хирургических специальностей, преподавателей и студентов медицинских вузов.

Ключевые слова: пластические материалы, детская кардиохирургия.

Год издания: 2016

Издательство: ОДО «Беловагрупп»

ISBN 978-985-7154-08-1

DOI: 10.31997/978-985-7154-08-1

Ссылка для цитирования:
Дроздовский, К. В. Пластические материалы в современной детской кардиохирургии / К. В. Дроздовский, Ю. И. Линник; под ред. К. В. Дроздовского. – Минск : Беловагрупп, 2016. – 98 с. https://doi.org/10.31997/978-985-7154-08-1

 

Список источников:

  1. A comparison of failure modes of glutaraldehyde treated versus antibiotic preserved mitral valve allografts implanted in sheep / K. Tamura [et al.] // J. Thorac. Cardiovasc. Surg. – 1995. – Vol. 110, № 1. – P. 224–238.
  2. A comparison of free skin graft, fascia lata, alloderm, bovine pericardium and primary repair in urethrocutaneous fistulas without diversion: an experimental study / A. Ayyildiz [et al.] // Ann. Thorac. Surg. – 2006. – Vol. 82, № 3. – P. 1113–1115.
  3. A new antithrombogenic RV PA valved conduit / Y. Ichikawa [et al.] // ASAIO J. – 1994. – Vol. 40, № 3. – P. 714–718.
  4. A newly developed porcine heart valve bioprosthesis fixed with an epoxy compound. An experimental evaluation / H.W. Sung [et al.] // ASAIO J. – 1994. –Vol. 40, №2.–P. 192–198.
  5. Actuarial versus actual risk of porcine structural valve deterioration / G.L. Grunkemeier [et al.] // J. Thorac. Cardiovasc. Surg. – 1994. – Vol. 108, № 4. – P. 709–718.
  6. An in vitro diffusion model for the study of calcification of bovine pericardium tissue / B.B. Tomazic [et al.] // J. Pharm. Sci. – 1997. – Vol. 86, № 12. – P. 1432–1438.
  7. Anderson, E.T. Long-term follow up of aortic valve replacement with fresh aortic homograft / E.T. Anderson, E.W. Hancock // J. Thorac. Cardiovasc. Surg. – 1976. – Vol. 72:150–156.
  8. Anselme, K. Inhibition of calcification in vivo by acyl azide cross linking of a collagen glycosaminoglycan sponge / K. Anselme, H. Petite, D. 76 Herbage // Matrix. – 1992. – Vol. 12, № 4. – P. 264–273.
  9. Aortic reconstruction with crimped bovine pericardial conduits / С A. Salles [et al.] // J. Heart Valve Dis. – 1998. – Vol. 7, № 3. – P. 305–312.
  10. Aortic valve replacement with cryopreserved aortic allograft. Ten year experience / J.R. Doty [et al.] // J. Thorac. Cardiovasc. Surg. – 1998. – Vol. 115, № 2.–P. 371–380.
  11. Aortic valve replacement with stentless porcine aortic valves. A ten year experience / Т.Е. David [et al.] // J. Heart Valve Dis. – 1998. – Vol. 7, № 3. – P. 250–254.
  12. Aortic valve replacement with the freestyle stentless xenograft / S. Westaby [et al.] // Ann. Thorac. Surg. – 1995. – Vol. 60, № 2. – Suppl. – P. S422–427.
  13. Bajpai, P.K. Immunogenicity of tanned tissue valve xenografts / P.K. Bajpai // Biomaterials in reconstructive surgery / ed. L.R. Rubin The C.V. – N.Y.: Mosby Company, 1983. – P. 735–752.
  14. Barratt-Boyes, B.G. Homograft aortic valve replacement in aortic incompetence and stenosis / B.G. Barratt-Boyes // Thorax. – 1964. – Vol.19. – P. 131–150.
  15. Barratt-Boyes, B.G. Cardiothoracic surgery in the antipodes / B.G. Barratt-Boyes // Thor. Cardiovasc. Surg. – 1979. – Vol. 78. – P. 804–822.
  16. Biocompatibility study of a biological tissue fixed with a naturally occurring crosslinking reagent / L.L. Huang [et al.] // J. Biomed. Mater. Res. – 1998. – Vol. 42, № 4. – P. 568–576.
  17. Biomechanical and ultrastructural comparison of cryopreservation and 77 a novel cellular extraction of porcine aortic valve leaflets / D.W. Courtman [et al.] // J. Biomed. Mater. Res. – 1995. –Vol. 29, № 12. –P. 1507–1516.
  18. Biomechanics of glutaradehyde treated porcine aortic roots and valves / K.J. Lockie [et al.] // J. Thorac. Cardiovasc. Surg. – 1994. – Vol. 108, № 6. – P. 1037–1042.
  19. Calcification of bovine pericardium: glutaraldehyde versus No–React biomodification / A. Abolhoda [et al.] // Ann. Thorac. Surg. – 1996. – Vol. 62, № 1. – P. 169–174.
  20. Calcium mitigation in bioprosthetic tissues by iron pretreatment. The challenge of iron leaching / S.M. Carpentier [et al.] // Ann. Thorac. Surg. – 1995. – Vol. 60, № 2. – P. S332–338.
  21. Carpentier Edwards standard porcine bioprosthesis. a 21 year experience / W.R. Jamieson [et al.] // Ann. Thorac. Surg. – 1998. – Vol. 66, № 6. – P. S40–43.
  22. Chachques, J.C. Current status of valvular surgery / J.C. Chachques, M. Pellerin // Curr. Opin. Cardiol. – 1994. – Vol. 9, № 2. – P. 186–190.
  23. Chanda, J. Anticalcification treatment of pericardial prostheses / J. Chanda // Biomaterials. – 1994. – Vol. 15, № 6. – P. 465–469.
  24. Chanda, J. Prevention of calcification in glutaraldehyde treated porcine aortic and pulmonary valves / J. Chanda, R. Kuribayashi, T. Abe // Ann. Thorac. Surg. –1997. – Vol. 64, № 4. – P. 1063–1066.
  25. Chen, W. Mechanism of efficacy of 2 amino oleic acid for inhibition of calcification of glutaraldehyde pretreated porcine bioprosthetic heart valves / W. Chen, F.J. Schoen, R.J. Levy // Circulation. – 1994. – Vol. 90, № 1. – P. 323–329. 78
  26. Chvapil, M. Effect of collagen crosslinking on the rate of resorption of implanted collagen tubing in rabbits / M. Chvapil, J.A. Owen, D.S. Clark // J. Biomed. Materials Res. – 1977. – Vol. 11, № 2. – P. 297–314.
  27. Comparative analysis of glutaraldehyde preserved porcine xenografts and fresh or glutaraldehyde treated human aortic valves by holographic interferometry / A.W. Geiger [et al.] // Cardiovasc. Surg. – 1994. – Vol. 2, № 6. – P. 693–697.
  28. Comparison of different anticalcification treatments for stentless bioprostheses / T. Walther [et al.] // Ann. Thorac. Surg. – 1998. – Vol. 66, № 6. – P. S249–254.
  29. Craig, S.R. The use of bovine internal mammary artery (Bioflow) grafts in coronary artery surgery / S.R. Craig, W.S. Walker // Eur. J. Cardiothorac. Surg. – 1994. – Vol. 8, № 1. – P. 43–15.
  30. Degradation potential of biological tissues fixed with various fixatives, an in vitro study / H.W. Sung [et al.] // J. Biomed. Mater. Res. – 1997. – Vol. 35, № 2. –P. 147–155.
  31. Desai, N.D. Bioprosthetic aortic valve replacement: Stented pericardial and porcine valves// N.D. Desai, Christakis G.T. / Cardiac surgery in the adult // ed. L.H. Cohn – Copyright by McGraw Hill Companies, Inc. – 2008. – P. 857–894.
  32. Detoxified glutaraldehyde cross linked pericardium: tissue preservation and mineralization mitigation in a subcutaneous rat model / M. Valente [et al.] // J. Heart Valve Dis. – 1998. – Vol. 7, № 3. – P. 283–291.
  33. Early failure of an autologous pericardium aortic heart valve. M. Dahm [et al] // J. Heart Valve Dis. – 1998. – Vol. 7, № 1. – P. 30–33. 79
  34. Epoxy compounds as a new cross linking agent for porcine aortic leaflets, subcutaneous implant studies in rats / E. Imamura [et al.] // J. Cardiac Surg. – 1989. – Vol. 4, №l.–P. 50–57.
  35. Evaluation of epoxy ether fixed bovine arterial grafts for mutagenic potential / J.M. Lohre [et al.] // ASAIO J. – 1993. – Vol. 39, № 2. – P. 106–113.
  36. Extended survival of a porcine mitral bioprosthesis for 23 years, report of a case / T. Baba [et al] // Surg. Today. – 1999. – Vol. 29, № 6. – P. 573–574.
  37. Factors in the early failure of cryopreserved homograft pulmonary valves in children. Preserved immunogenicity? / R.J. Baskett [et al.] // J. Thorac. Cardiovasc. Surg. – 1996. – Vol. 112, № 5. – P. 1170–1178.
  38. Feasibility evaluation of a new pericardial bioprosthesis with dye mediated photo–oxidized bovine pericardial tissue / R.W. Bianco [et al.] // Journal Of Heart Valve Disease. – 1996. – Vol. 5, № 3. – P. 317–322.
  39. Fourteen year experience with homovital homografts for aortic valve replacement / M. Yacoub [et al.] // J. Thorac. Cardiovasc. Surg. – 1995. – Vol. 110, №1. – P. 186–193.
  40. Girardot, J.M. Amide cross–linking: An alternative to glutaraldehyde fixation / J.M. Girardot, M.N. Girardot // J. Heart. Valve. Dis. – 1996. – Vol. 5. – P.518–525.
  41. Girardot, J.M., Amide cross–linking: an alternative to glutaraldehyde fixation / J.M. Girardot, M.N. Girardot // Journal Of Heart Valve Disease. – 1996. – Vol. 5, № 5. – P.518–525.
  42. Glutaraldehyde detoxification of aortic wall tissue, a promising perspective for emerging bioprosthetic valve concepts / P. Zilla [et al.] // J. Heart Valve Dis. –1997. – Vol. 6, № 5. – P. 510–520.
  43. Glutaraldehyde tanned bovine carotid artery graft for infrainguinal vascular reconstruction. 5 year follow up / R.J. Holdsworth [et al.] // Eur. J. Vase. Endovasc. Surg. – 1997. – Vol. 14, № 3. – P. 208–211.
  44. Haemodynamic performance of aortic pericardial bioprostheses and bileaflet prostheses at rest and during exercise. Implications for the surgical management of patients with small aortic roots / J.R. Gonzalez Juanatey [et al.] // Heart. – 1999. – Vol. 82, №2. – P. 149–155.
  45. Hemodynamic benefits of the Toronto Stentless Valve / D.F. Del Rizzo [et al.] // J. Thorac. Cardiovasc. Surg. – 1996. – Vol. 112, № 6. – P. 1431–1445.
  46. Heterologous mitral valve transplant. The first 50 patients clinical analysis / M.P. Vrandecic [et al.] // Eur. J. Cardiothorac. Surg. – 1995. Vol. 9, № 2. – P. 69–73.
  47. Homotransplantation of the aortic valve / A.C. Beall [et al.] // Thorac. Cardiovasc. Surg. – 1961. – Vol. 42. – P. 497–506.
  48. Huysmans, H.A. Stentless Bioprostheses / H.A. Huysmans, Т.Е. David, S. Westaby. // ISIS Medical media. Second Edition. Taylor & Francis e– Library. – 2006. – P. 302–317.
  49. Jarrett, F. Long term results of femoropopliteal bypass with stabilized human umbilical vein / F. Jarrett, B.A. Mahood // Am. J. Surg. – 1994. – Vol. 168, № 2. – P. 111–114.
  50. Korossis, S. Biomechanics and hydrodynamics of decellularised aortic valves for tissue engineering / S. Korossis // MSc Thesis. The School of Mechanical Engineering, University of Leeds, Leeds, UK. – 2002. – P. 114–120.
  51. Korossis, S.A. Tissue engineering of cardiac valve prostheses II: 81 biomechanical characterization of decellularized porcine aortic heart valves / S.A. Korossis, C. Booth, H.E. Wilcox // J. Heart Valve Dis. – 2002. – Vol.11. – P. 463–471.
  52. Late results of clinical experience with small caliber biological grafts / J. Ninomiya [et al.] // Artif. Organs. – 1995. – Vol. 19, № 1. – P. 46–50.
  53. Lee, J.M. Mechanical properties of human pericardium. Differences in viscoelastic response when compared with canine pericardium / J.M. Lee, D.R. Boughner // Circulation Research. – 1985. – Vol. 57. – P. 475–481.
  54. Long term results of the Carpentier Edwards pericardial aortic valve, a 12 year follow up / M.K. Banbury [et al.] // Ann. Thorac. Surg. – 1998. – Vol. 66, № 6. – P. 73–76.
  55. Miller, D.C. «Fresh» aortic homografts: long-term results with freehand aortic valve replacement / D.C. Miller // J Cardiac Surg. – 1987. – Vol. 2.т– P. 185–191.
  56. Mirsadraee, S. Development and characterization of an acellular human pericardial matrix for tissue engineering / S. Mirsadraee, H.E. Wilcox, S.A.тKorossis // Tissue Eng. – 2006. – Vol. 12. – P. 763–773.
  57. Moore, M.A. Biocompatibility and immunologic properties of pericardial tissue stabilized by dye mediated photooxidation / M.A. Moore, R.E.Jr. Phillips // J. Heart Valve Dis. – 1997. – Vol. 6, № 3. – P. 307–315.
  58. Multicenter study of stentless valve replacement in the small aortic root / U. Hvass [et al.] // J. Thorac. Cardiovasc. Surg. – 1999. – Vol. 117, № 2. – P. 267–272.
  59. Myers, D.J. A comparison between glutaraldehyde and diepoxide fixed stentless porcine aortic valves, biochemical and mechanical characterization and resistance to mineralization / D.J. Myers, J. Gross, G. Nakaya // J. Heart Valve Dis. – 1995. – Vol. 4, № 1. – P. 98–101.
  60. No–react anticalcification tissue treatment results with stentless heart valves in two adolescents / M. Simcha [et al.] // J. Thorac. Cardiovasc. Surg. –1999. –Vol. 117. – P. 1222–1223.
  61. Penta, A. Patient status 10 or more years after «fresh» homograft replacement of the aortic valve / A. Penta, S. Qureshi, R. Radley-Smith // Circulation. – 1984. – Vol. 70, № I. – P. 1182–1186.
  62. Photo oxidized bovine arterial grafts, short term results / N. Moazami [et al.] // ASAIO J. – 1998. – Vol. 44, № 1. – P. 89– 93.
  63. Polyethylene glycol (PEG) modified bovine pericardium as a biomaterial: a comparative study on immunogenicity / S. Aravind [et al.] // J. Biomater. Appl. – 1999. – Vol. 13, № 2. – P. 158–165.
  64. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms / N. Vyavahare [et al.] // Circulation –1997. – Vol. 95, №2.–P. 479–488.
  65. Prosthetic replacement of the tricuspid valve. Biological or mechanical? / G. Rizzoli [et al.] // Ann. Thorac. Surgery – 1998. – Vol 66, № 6. – Suppl. – P. 62–67.
  66. Pulmonary valve replacement in children / E. Saro Servando [et al.] // Ann. Chir. – 1996. – Vol. 50, № 8. – P. 703–706.
  67. Rajani, B. Evidence for rejection of homograft cardiac valves in infants / B. Rajani, R.B. Mee, N.B. Ratliff // J. Thorac. Cardiovasc. Surg. – 1998. – Vol. 115, № l. – P. 111–117.
  68. Robicsek, F. The application of biological tissues in cardiac valve surgery. The history of the first two decades./ F. Robicsek // J. Heart Valve Dis. – 1994. – Vol. 3, № 6. – P. 613–626.
  69. Ross, D. Homograft replacement of the aortic valve: a critical review / D. Ross, M.H. Yacoub // Prog. Cardiovasc. Dis. – 1969. – Vol. 11. – P. 275–293.
  70. Ross, D.N. Homograft replacement of the aortic valve / D.N. Ross // Lancet. –1962. – Vol. 2, № 7254. – P. 487–488.
  71. Ross, D.N. The pulmonary autograft, history and basic techniques / D.N. Ross // Semin. Thorac. Cardiovasc. Surg. – 1996. – Vol. 8, № 4. – P. 350–357.
  72. Saravalli, O.A. Calcification of aortic homografts used for reconstruction of the right ventricular outflow tract / O.A. Saravalli, J. Somerville, K.E.Jefferseon // J. Thorac. Cardiovasc. Surg. – 1980. – Vol. 80. – P. 909–920.
  73. Sauren, A.A. The mechanical properties of porcine aortic valve tissues / A.A. Sauren, M.C., van Hout A.A. van Steenhoven // J. Biomech. – 1983. – Vol. 16, № 5. – P. 327–337.
  74. Schoen, F.J. Tissue heart valves: current challenges and future research perspectives / F.J. Schoen, R.J. Levy // J. Biomed. Mater. Res. – 1999. – Vol. 47, № 4. – P. 439–465.
  75. Schoen, F.J. Pathologic findings in explanted clinical bioprosthetic valves fabricated from photooxidized bovine pericardium / F.J. Schoen // J. Heart Valve Dis. – 1998. – Vol. 7, № 2. – P. 174–179.
  76. Senning, A. Fascia lata replacement of aortic valves / A. Serming // J. Thorac. Cardiovasc. Surg. – 1967. – Vol. 54, № 4. – P. 465–470.
  77. Shanthi, C. New treatments using alginate in order to reduce the calcification of bovine bioprosthetic heart valve tissue / С Shanthi, K.P. Rao // J. Biomater. Sci. Polym. Ed. – 1997. – Vol. 8, № 12. – P. 919–930.
  78. Shrinkage temperature versus protein extraction as a measure of stabilization of photooxidized tissue / M.A. Moore [et al.] // J. Biomed. Mater. Res. – 1996. – Vol. 32, №2. – P. 209–214.
  79. Stelzer, P. Pulmonary autograft: an American experience / P. Stelzer, R.C. Elldns // J. Cardiac. Surg. – 1987. – Vol. 2. – P. 429–433.
  80. Stelzer, P. Stentless aortic valve replacement: porcine and pericardial. / P. Stelzer // Cardiac surgery in the adult / ed. L.H. Cohn – Copyright by McGraw Hill Companies, Inc., 2008. – P. 915– 934.
  81. Stentless aortic valve replacement with the biocor prosthesis, indications and outcome / M. Achtelik [et al.] // J. Heart Valve Dis. – 1996. – № 3. – P. 314–316.
  82. Strobel, R. Aneurysm formation in modified human umbilical vein grafts / R. Strobel, A.H. Boontje, J.J. Van Den Dungen // Eur. J. Vase. Endovasc. Surg. – 1996. – Vol. 11, №4. – P. 417–420.
  83. Sung, H.W. Effects of various chemical sterilization methods on the crosslinking and enzymatic degradation characteristics of an epoxy fixed biological tissue / H.W. Sung, H.L. Hsu, C.S. Hsu // J. Biomed. Mater. Res. – 1997. – Vol. 37, №3. – P. 376–383.
  84. Teply, J.F. The ultimate prognosis after valve replacement: an assessment of twenty years / J.F. Teply, G.L. Grunkemeier, S.H. D’Arcy // Ann. Thorac. Surg. – 1981. – Vol. 32. – P. 111–119.
  85. The Carbomedics «Oxford» Photofix stentless valve (PSV) / S. Westaby [et al.] // Semin. Thorac. Cardiovasc. Surg. – 1999. – Vol. 11, № 4. – P. 206–209.
  86. The Hancock II bioprosthesis at 12 years / Т.Е. David [et al.] // Ann. Thorac. Surg. – 1998. –Vol. 66, № 6. – P. 95–98.
  87. Thompson, R. The use of «fresh» unstented homograft valves for replacement of the aortic valve / R. Thompson, M.H. Yacoub, M. Ahmed // Thorac. Cardiovasc. Surg. –1980. – Vol. 79. – P. 896–903.
  88. Thompson, R. Influence of preoperative left ventricular function on results of homograft replacement of aortic valve for aortic regurgitation / R. Thompson, M. Yacoub, R. Seabra-Gomes // Thorac. Cardiovasc. Surg. – 1979. – Vol. 77. – P. 411–421.
  89. Thompson, R. Influence of preoperative left ventricular function on results of homograft replacement of the aortic valve for aortic stenosis / R. Thompson, M.H. Yacoub, M. Ahmed // Am. J. Cardiol. – 1979. – Vol. 43. – P. 929–938.
  90. Time dependent effect of glutaraldehyde on the tendency to calcify of both autografts and xenografts / K. Liao [et al.] // Ann. Thorac. Surg. – 1995. – Vol. 60, № 2. – P. 343–347.
  91. Tomizawa, Y. Vascular prostheses for aortocoronary bypass graftings A review / Y. Tomizawa // Artif Organs. – 1995. – Vol. 19, № 1. – P. 39–45.
  92. Twelve year follow up with the Sorin Pericarbon bioprosthesis in the mitral position / P.P. Caimmi [et al.] // J. Heart Valve Dis. – 1998. – Vol. 7, № 4. – P. 400–406.
  93. Use of a bovine jugular vein graft with natural valve for right ventricular outflow tract reconstruction: a one year animal study / Y. Ichikawa [et al.] // J. Thorac. Cardiovasc. Surg. – 1997. – Vol. 114, № 2. – P. 224–233.
  94. Use of diphenylphosphorylazide for cross linking collagen based biomaterials / H. Petite [et al.] // J. Biomed. Mater. Res. – 1994. – Vol. 28, № 2. – P. 159–165.
  95. Vasudev, S.C. Glutaraldehyde treated bovine pericardium: changes in calcification due to vitamins and platelet inhibitors / S.C. Vasudev, T. Chandy, C.P. Sharma // Artificial Organs. – 1997. – Vol. 21, № 9. – P. 1007–1013.
  96. Vasudev, S.C. The antithrombotic versus calcium antagonistic effects of polyethylene glycol grafted bovine pericardium / S.C. Vasudev, T. Chandy, C.P. Sharma // J. Biomater. Appl. – 1999. – Vol. 14, № 1. – P. 48–66.
  97. Wassenaar, C. Cracks in cryopreserved aortic allografts and rapid thawing / C. Wassenaar, E.G. Wijsmuller, L.A. Van Herwerden // Ann. Thorac. Surg. – 1995. – Vol. 60. – P. 165–167.
  98. Wengerter, K. Biological vascular grafts / K. Wengerter, H. Dardik // Semin. Vase. Surg. – 1999. – Vol. 12, № 1. – P. 46–51.